Robin E. Buckingham

11.4k citations

62 papers · 4.8k indexed · h-index 33

Impact in

Endocrine and Autonomic Systems top 0.5%
- Regulation of Appetite and Obesity
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Treatment and Management

Papers in ⓘ

Endocrine and Autonomic Systems 19
- Regulation of Appetite and Obesity 18
Biochemistry 7
- Eicosanoids and Hypertension Pharmacology 7

Co-authors: Jonathan R.S. Arch (12 shared papers)Peter Widdowson (8 shared papers)Mohammad Tadayyon (5 shared papers)Shelagh Wilson (6 shared papers)Thomas C. Hamilton (8 shared papers)G. Williams (5 shared papers)John C. Clapham (7 shared papers)Lucy Pickavance (8 shared papers)
Journals: Diabetes (11 papers)British Journal of Pharmacology (7 papers)Diabetes Obesity and Metabolism (6 papers)Peptides (4 papers)Journal of Pharmacy and Pharmacology (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Robin E. Buckingham

62 papers receiving 4.6k citations

Peers

Countries citing papers authored by Robin E. Buckingham

Since Specialization

Citations

This map shows the geographic impact of Robin E. Buckingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin E. Buckingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin E. Buckingham more than expected).

Fields of papers citing papers by Robin E. Buckingham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin E. Buckingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin E. Buckingham. The network helps show where Robin E. Buckingham may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin E. Buckingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin E. Buckingham Line = papers co-authored together Robin E. Buckingham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes Circulation ·Michaela Scheuermann‐Freestone, Per Lav Madsen, David Neil Manners, Andrew M. Blamire, Robin E. Buckingham, Peter Styles, George K. Radda, Stefan Neubauer, Kieran Clarke	2003	403
2	β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats Diabetes ·Diane T. Finegood, M. Dawn McArthur, David Kojwang, Marion J. Thomas, Brian Topp, Thomas B. Leonard, Robin E. Buckingham	2001	312
3	Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat Peptides ·Andrea Haynes, Brian A. Jackson, Philip Overend, Robin E. Buckingham, Shelagh Wilson, Mohammad Tadayyon, Jonathan R.S. Arch	1999	263
4	In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist Rosiglitazone Circulation ·Tianli Yue, Jun Chen, Weike Bao, Padma Kumar Narayanan, Antoine Bril, Wen Jiang, Paul G. Lysko, Juan-Li Gu, Rogely Boyce, Dawn Zimmerman, Timothy K. Hart, Robin E. Buckingham, Eliot H. Ohlstein	2001	261
5	Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes ·Xue Cai, Peter Widdowson, Joanne A. Harrold, Shelagh Wilson, Robin E. Buckingham, J R Arch, M. Tadayyon, John C. Clapham, John Wilding, Gareth Williams	1999	254
6	Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat Diabetes ·Q. Wang, C. Bing, K. Al-Barazanji, D. E. Mossakowaska, X. M. Wang, D. L. McBay, W. A. Neville, M. Taddayon, Lucy Pickavance, Simon Dryden, M. E. Thomas, M. T. McHale, I. S. Gloyer, S. Wilson, Robin E. Buckingham, Jonathan R.S. Arch, Paul Trayhurn, Gary L. Williams	1997	236
7	Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆ Peptides ·David J. Cutler, Richard Morris, Vimal Sheridhar, Trevor A.K Wattam, S. Holmes, Sara Patel, Jonathan R.S. Arch, Shelagh Wilson, Robin E. Buckingham, Martyn L. Evans, Ron A. Leslie, Gareth Williams	1999	194
8	Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Protects Against Nephropathy and Pancreatic Islet Abnormalities in Zucker Fatty Rats Diabetes ·Robin E. Buckingham, Kamal Albarazanji, C. D. N. Toseland, Mark S. Slaughter, Susan C. Connor, Andrew West, Brian Bond, Nicholas C. Turner, John C. Clapham	1998	184
9	Inhibition of Food Response to Intracerebroventricular Injection of Leptin Is Attenuated in Rats With Diet-Induced Obesity Diabetes ·Peter Widdowson, R Upton, Robin E. Buckingham, Jonathan R.S. Arch, G. Williams	1997	178
10	Central Exendin‐4 Infusion Reduces Body Weight without Altering Plasma Leptin in (fa/fa) Zucker Rats Obesity Research ·Kamal Albarazanji, Jonathan R.S. Arch, Robin E. Buckingham, Mohammad Tadayyon	2000	171
11	The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes ·Adrian B Walker, Paula Chattington, Robin E. Buckingham, G. H. Williams	1999	163
12	Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH2-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury Diabetes ·Nassirah Khandoudi, Philippe Delerive, Isabelle Berrebi‐Bertrand, Robin E. Buckingham, Bart Staels, Antoine Bril	2002	156
13	Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans Journal of Medicinal Chemistry ·Valerie A. Ashwood, Robin E. Buckingham, Frederick Cassidy, John Evans, E. A. FARUK, Thomas C. Hamilton, David J. Nash, Geoffrey Stemp, K. WILLCOCKS	1986	150
14	Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution British Journal of Pharmacology ·Lucy Pickavance, Mohammad Tadayyon, Peter Widdowson, Robin E. Buckingham, John Wilding	1999	142
15	Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart Diabetes ·Robert J. Sidell, Mark A. Cole, Nicholas J. Draper, Martine Desrois, Robin E. Buckingham, Kieran Clarke	2002	140
16	Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat British Journal of Pharmacology ·Robin E. Buckingham, Thomas C. Hamilton, David Howlett, Sheila Mootoo, Campbell Wilson	1989	107
17	Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats Diabetes ·Robin E. Buckingham, K. A. Al-Barazanji, C. D. Toseland, M. Slaughter, S. C. Connor, A. West, Braden Bond, N. C. Turner, J. C. Clapham	1998	91
18	Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes ·Adrian B Walker, Ebrahim Naderali, Paula Chattington, Robin E. Buckingham, Gareth Williams	1998	88
19	Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster Journal of Biological Chemistry ·André C. Carpentier, Changiz Taghibiglou, Nathalie Leung, Linda Szeto, Stephen C. Van Iderstine, Kristine D. Uffelman, Robin E. Buckingham, Khosrow Adeli, Gary F. Lewis	2002	86
20	BRL 34915, A Novel Antihypertensive Agent: Comparison of Effects on Blood Pressure and Other Haemodynamic Parameters with Those of Nifedipine in Animal Models Journal of Cardiovascular Pharmacology ·Robin E. Buckingham, John C. Clapham, Thomas C. Hamilton, Susan D. Longman, Joseph Norton, R H Poyser	1987	84

About Robin E. Buckingham

Robin E. Buckingham is a scholar working on Endocrine and Autonomic Systems, Biochemistry, Physiology, Behavioral Neuroscience and Cellular and Molecular Neuroscience, having authored 62 papers that have together received 4.8k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (19 papers), Regulation of Appetite and Obesity (18 papers), Adipose Tissue and Metabolism (17 papers), Receptor Mechanisms and Signaling (9 papers), Eicosanoids and Hypertension Pharmacology (7 papers), Nitric Oxide and Endothelin Effects (6 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Neuropeptides and Animal Physiology (6 papers). The work is most often cited by research in Endocrine and Autonomic Systems (1.4k citations), Endocrinology, Diabetes and Metabolism (850 citations), Physiology (1.2k citations), Cognitive Neuroscience (728 citations) and Cardiology and Cardiovascular Medicine (858 citations). Robin E. Buckingham has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Jonathan R.S. Arch, Peter Widdowson, Mohammad Tadayyon, Shelagh Wilson, Thomas C. Hamilton, G. Williams, John C. Clapham, Lucy Pickavance, John Wilding and Kieran Clarke. Their work appears in journals such as Diabetes, British Journal of Pharmacology, Diabetes Obesity and Metabolism, Peptides and Journal of Pharmacy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact